Yuyu Pharma Cancels 1.28 Million Treasury Shares, Boosting Shareholder Value through 7.5% Reduction in Outstanding Shares
Yuyu Pharma decided to cancel 1,284,889 common shares and 2,600 preferred shares held as treasury stock through a board resolution.
The cancelled shares consist of 1,116,638 shares acquired within distributable range, 168,251 shares from merger, and 2,600 shares from stock dividends, reducing total outstanding shares without affecting capital.
After cancellation, outstanding shares will decrease to 15,747,462 common and 2,589,890 preferred shares, a reduction of approximately 6.6% of total shares, which is expected to boost earnings per share and stock price.
This treasury share cancellation represents an active shareholder return policy, positively impacting stock outlook along with potential future dividend increases.
[AI Summary]Yuyu Pharma's treasury share cancellation reduces outstanding shares by 6.6%, immediately improving earnings per share and strengthening shareholder returns without capital reduction. Utilizing existing treasury shares avoids new funding while maximizing shareholder value, reflecting a sound capital allocation strategy.